Cargando…
A trade‐off: Antimicrobial resistance and COVID‐19
As we combat the COVID‐19 pandemic, both the prescription of antimicrobials and the use of biocidal agents have increased in many countries. Although these measures can be expected to benefit existing people by, to some extent, mitigating the pandemic's effects, they may threaten long‐term well...
Autor principal: | Johnson, Tess |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652952/ https://www.ncbi.nlm.nih.gov/pubmed/34464462 http://dx.doi.org/10.1111/bioe.12928 |
Ejemplares similares
-
Impact of COVID-19 on Antimicrobial Use and Resistance in an Urban Safety-Net Community Hospital
por: Lora, Alfredo Mena, et al.
Publicado: (2021) -
Operational challenges of the Philippine Antimicrobial Resistance Surveillance Program during the COVID-19 pandemic
por: Boehme, Karis, et al.
Publicado: (2022) -
Strengthening health systems resilience using environmental surveillance for COVID-19 and antimicrobial resistance in the Philippines
por: Salazar, Miguel Antonio, et al.
Publicado: (2022) -
Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study
por: Reed, Shelby, et al.
Publicado: (2020) -
Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan
por: Ul Mustafa, Zia, et al.
Publicado: (2021)